CytomX Therapeutics, Inc.

NasdaqGS:CTMX Stock Report

Mkt Cap: US$166.5m

CytomX Therapeutics Company Information

CytomX Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: CytomX Therapeutics, Inc.
  • Ticker: CTMX
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$166.533m
  • Shares outstanding: 66.08m
  • Website: https://www.cytomx.com

Number of Employees


Location

  • CytomX Therapeutics, Inc.
  • 151 Oyster Point Boulevard
  • Suite 400
  • South San Francisco
  • California
  • 94080
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CTMXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDOct 2015
6C1DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/23 00:00
End of Day Share Price2023/01/20 00:00
Earnings2022/09/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.